QUEST DIAGNOSTICS INC
For the period ended Sep 30, 2024. Filed Oct 23, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Oct 23, 2024
DGX$259.67+1.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| 3.1 | Restated Certificate of Incorporation |
| 3.2 | Amended and Restated By-Laws of Quest Diagnostics Incorporated, as amended August 14, 2024 (filed as Exhibit 3.1 to the Company’s current report on Form 8-K (Date of Report: August 14, 2024) and incorporated herein by reference) (Commission File Number 001-12215) |
| 4.1 | Twenty-Third Supplemental Indenture, dated as of August 19, 2024, between the Company and the Bank of New York (filed as Exhibit 4.2 to the Company’s current report on Form 8-K (Date of Report: August 14, 2024) and incorporated herein by reference) (Commission File Number 001-12215) |
| 4.2 | Form of 4.600% Senior Note due 2027 (filed as Exhibit 4.3 to the Company’s current report on Form 8-K (Date of Report: August 14, 2024) and incorporated herein by reference) (Commission File Number 001-12215) |
| 4.3 | Form of 4.625% Senior Note due 2029 (filed as Exhibit 4.4 to the Company’s current report on Form 8-K (Date of Report: August 14, 2024) and incorporated herein by reference) (Commission File Number 001-12215) |
| 4.4 | Form of 5.000% Senior Note due 2034 (filed as Exhibit 4.5 to the Company’s current report on Form 8-K (Date of Report: August 14, 2024) and incorporated herein by reference) (Commission File Number 001-12215) |
| 22 | Subsidiary Guarantors of Securities |
| 31.1 | Rule 13a-14(a) Certification of Chief Executive Officer |
| 31.2 | Rule 13a-14(a) Certification of Chief Financial Officer |
| 32.1 | Section 1350 Certification of Chief Executive Officer |
| 32.2 | Section 1350 Certification of Chief Financial Officer |
| 101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document - dgx-20240930.xsd |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document - dgx-20240930_cal.xml |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document - dgx-20240930_def.xml |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document - dgx-20240930_lab.xml |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document - dgx-20240930_pre.xml |
| 104 | Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101) |
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
October 23, 2024
Quest Diagnostics Incorporated
| By | /s/ James E. Davis |
|---|---|
| James E. Davis | |
| Chairman, Chief Executive Officer | |
| and President | |
| By | /s/ Sam A. Samad |
| Sam A. Samad | |
| Executive Vice President and | |
| Chief Financial Officer |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.